Streetbeat News

Regulatory

SPY

UUP

The Federal Reserve's preferred inflation measure, the core PCE index, rose slightly more than expected in September, potentially affecting future interest rate cuts. Personal income and spending also increased, while markets showed minimal reaction to the inflation data.

Portfolio Pulse from Piero Cingari

October 31, 2024 | 12:57 pm

INTC

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSM) reports that Super Typhoon Kong-rey is not expected to impact its operations. The company has activated typhoon alert procedures. TSM faces geopolitical challenges, including tensions between the U.S. and China, and has suspended chip shipments to firms linked to Huawei. Intel's comments on Taiwan's geopolitical risks have led TSM to retract discounts for Intel, affecting their partnership. TSM stock is up 92% year-to-date but has seen a recent decline.

Portfolio Pulse from Anusuya Lahiri

October 31, 2024 | 12:45 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX) has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing. The company's stock maintained a closing bid price of at least $1.00 for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

SPY

The Core PCE Price Index for September increased by 2.7% year-over-year, slightly above the estimated 2.6%. This indicates a modest rise in inflation, which could influence market expectations regarding interest rates and economic growth.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:30 pm

SRRK

Scholar Rock will present new clinical and biomarker data from the Phase 1 DRAGON trial at the SITC 39th Annual Meeting. The presentation will include safety, efficacy, and biomarker data for SRK-181 in patients with advanced solid tumors.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:24 pm

APLI

Appili Therapeutics shares rose following the company's announcement of alignment with the FDA on development requirements for its ATI-1801 topical antiparasitic product.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:23 pm

TSLA

Tesla plans to expand its 'Actually Smart Summon' feature to Europe, China, and other regions, following its U.S. release. The feature allows Tesla cars to be summoned to specific locations via the Tesla app. The company also plans to roll out its full self-driving software in Europe and China by Q1 2025, pending regulatory approval.

Portfolio Pulse from Anan Ashraf

October 31, 2024 | 12:22 pm

AEE

Ameren Missouri, a subsidiary of Ameren Corporation, has received approval to build an 800MW natural gas energy center, Castle Bluff, expected to be operational by 2027. This $900 million investment aims to provide reliable backup energy, complementing renewable sources.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:19 pm

LPCN

Lipocine Inc. has entered into a distribution and license agreement with SPC Korea to commercialize TLANDO in South Korea. Lipocine will receive upfront, regulatory, and sales milestone payments, as well as royalties on net sales.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:12 pm

GLD

NEM

Newmont seeks to extend the permit for its Cadia mine in Australia until 2050, which would provide significant regional economic benefits and align with sustainability goals. The extension is under review by the NSW Department of Planning.

Portfolio Pulse from Stjepan Kalinic

October 31, 2024 | 11:53 am